GlassScriptPhysician profile
Stephen Philip Karp
NPI 1881155877
$1,869.25
in general payments reported to CMS, 2019-2025
12 companies · $409 in 2025
The $409 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.25 · 2023: $559 · 2024: $873 · 2025: $409.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,841.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,841.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $628.93 | 2023-2025 | Intellis Adaptivestim, Cd Horizon Spinal System, Navlock |
| Abbvie INC. | $567.47 | 2023-2025 | |
| Lundbeck LLC | $216.37 | 2023-2024 | Vyepti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $148.54 | 2024-2025 | Relistor |
| Pfizer INC. | $116.31 | 2024 | |
| Averitas Pharma INC. | $60.36 | 2024 | Qutenza |
| Spinal Simplicity, LLC | $40.35 | 2025 | Ha Minuteman G3-R |
| Collegium Pharmaceutical, INC. | $31.05 | 2024 | Belbuca, Xtampza |
| Daiichi Sankyo INC. | $16.66 | 2025 | Enhertu |
| Merck Sharp & Dohme LLC | $16.21 | 2019 | |
| Foundation Fusion Solutions, LLC | $14.96 | 2024 | |
| Novo Nordisk INC | $12.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Karp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.